nodes	percent_of_prediction	percent_of_DWPC	metapath
Thioridazine—HTR2A—conduct disorder	0.843	1	CbGaD
Thioridazine—HTR7—autonomic nervous system—conduct disorder	0.00357	0.305	CbGeAlD
Thioridazine—HTR2A—autonomic nervous system—conduct disorder	0.00222	0.19	CbGeAlD
Thioridazine—Propiomazine—DRD4—conduct disorder	0.000835	0.0853	CrCbGaD
Thioridazine—Cyamemazine—HTR2A—conduct disorder	0.000749	0.0766	CrCbGaD
Thioridazine—HTR6—brain—conduct disorder	0.000742	0.0634	CbGeAlD
Thioridazine—Methotrimeprazine—DRD4—conduct disorder	0.000714	0.073	CrCbGaD
Thioridazine—Promazine—DRD4—conduct disorder	0.000619	0.0632	CrCbGaD
Thioridazine—ADRA1B—brain—conduct disorder	0.000592	0.0506	CbGeAlD
Thioridazine—DRD1—brain—conduct disorder	0.000552	0.0472	CbGeAlD
Thioridazine—Chlorpromazine—DRD4—conduct disorder	0.000544	0.0556	CrCbGaD
Thioridazine—Zuclopenthixol—HTR2A—conduct disorder	0.000537	0.0549	CrCbGaD
Thioridazine—Acepromazine—HTR2A—conduct disorder	0.000481	0.0492	CrCbGaD
Thioridazine—Clomipramine—SLC6A4—conduct disorder	0.000476	0.0487	CrCbGaD
Thioridazine—Thioproperazine—HTR2A—conduct disorder	0.000471	0.0481	CrCbGaD
Thioridazine—Thiothixene—HTR2A—conduct disorder	0.000463	0.0473	CrCbGaD
Thioridazine—Pipotiazine—HTR2A—conduct disorder	0.000463	0.0473	CrCbGaD
Thioridazine—Mesoridazine—HTR2A—conduct disorder	0.000457	0.0467	CrCbGaD
Thioridazine—CHRM2—brain—conduct disorder	0.000445	0.038	CbGeAlD
Thioridazine—HTR2C—brain—conduct disorder	0.000429	0.0367	CbGeAlD
Thioridazine—Fluphenazine—HTR2A—conduct disorder	0.0004	0.0409	CrCbGaD
Thioridazine—Propiomazine—HTR2A—conduct disorder	0.000385	0.0393	CrCbGaD
Thioridazine—Clomipramine—HTR2A—conduct disorder	0.000366	0.0374	CrCbGaD
Thioridazine—HTR1A—brain—conduct disorder	0.000361	0.0309	CbGeAlD
Thioridazine—HTR7—brain—conduct disorder	0.000345	0.0295	CbGeAlD
Thioridazine—ADRA1A—brain—conduct disorder	0.000333	0.0284	CbGeAlD
Thioridazine—Methotrimeprazine—HTR2A—conduct disorder	0.000329	0.0336	CrCbGaD
Thioridazine—DRD2—brain—conduct disorder	0.000326	0.0279	CbGeAlD
Thioridazine—Promethazine—HTR2A—conduct disorder	0.000324	0.0331	CrCbGaD
Thioridazine—KCNH2—brain—conduct disorder	0.000321	0.0275	CbGeAlD
Thioridazine—Trifluoperazine—HTR2A—conduct disorder	0.00032	0.0327	CrCbGaD
Thioridazine—Perphenazine—HTR2A—conduct disorder	0.000316	0.0323	CrCbGaD
Thioridazine—CYP2C8—brain—conduct disorder	0.000294	0.0251	CbGeAlD
Thioridazine—Promazine—HTR2A—conduct disorder	0.000285	0.0292	CrCbGaD
Thioridazine—HRH1—brain—conduct disorder	0.000258	0.022	CbGeAlD
Thioridazine—ADRA2A—brain—conduct disorder	0.000253	0.0216	CbGeAlD
Thioridazine—Chlorpromazine—HTR2A—conduct disorder	0.000251	0.0257	CrCbGaD
Thioridazine—CYP2E1—brain—conduct disorder	0.000248	0.0212	CbGeAlD
Thioridazine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.00022	0.00162	CbGpPWpGaD
Thioridazine—CHRM2—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.000217	0.0016	CbGpPWpGaD
Thioridazine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.000217	0.0016	CbGpPWpGaD
Thioridazine—KCNH2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000216	0.00159	CbGpPWpGaD
Thioridazine—HTR2A—brain—conduct disorder	0.000215	0.0184	CbGeAlD
Thioridazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000214	0.00158	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—CGA—conduct disorder	0.000212	0.00156	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—CGA—conduct disorder	0.000211	0.00156	CbGpPWpGaD
Thioridazine—CYP2E1—Biological oxidations—COMT—conduct disorder	0.000211	0.00156	CbGpPWpGaD
Thioridazine—ADRA1B—G alpha (q) signalling events—HTR2A—conduct disorder	0.000211	0.00155	CbGpPWpGaD
Thioridazine—CYP2E1—Biological oxidations—MAOA—conduct disorder	0.000209	0.00154	CbGpPWpGaD
Thioridazine—CYP2E1—Metapathway biotransformation—COMT—conduct disorder	0.000208	0.00153	CbGpPWpGaD
Thioridazine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000206	0.00152	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—CGA—conduct disorder	0.000201	0.00148	CbGpPWpGaD
Thioridazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000199	0.00147	CbGpPWpGaD
Thioridazine—DRD1—GPCR ligand binding—DRD4—conduct disorder	0.000199	0.00147	CbGpPWpGaD
Thioridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000198	0.00146	CbGpPWpGaD
Thioridazine—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000198	0.00146	CbGpPWpGaD
Thioridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000197	0.00145	CbGpPWpGaD
Thioridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000197	0.00145	CbGpPWpGaD
Thioridazine—CYP2D6—brain—conduct disorder	0.000196	0.0168	CbGeAlD
Thioridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000194	0.00143	CbGpPWpGaD
Thioridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000193	0.00143	CbGpPWpGaD
Thioridazine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.000191	0.00141	CbGpPWpGaD
Thioridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00019	0.00141	CbGpPWpGaD
Thioridazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00019	0.0014	CbGpPWpGaD
Thioridazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000188	0.00139	CbGpPWpGaD
Thioridazine—ADRA1A—G alpha (q) signalling events—HTR2A—conduct disorder	0.000187	0.00138	CbGpPWpGaD
Thioridazine—CYP2C8—Biological oxidations—COMT—conduct disorder	0.000182	0.00134	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—CGA—conduct disorder	0.000182	0.00134	CbGpPWpGaD
Thioridazine—CYP2C8—Biological oxidations—MAOA—conduct disorder	0.000181	0.00134	CbGpPWpGaD
Thioridazine—CYP2C8—Metapathway biotransformation—COMT—conduct disorder	0.00018	0.00133	CbGpPWpGaD
Thioridazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000176	0.0013	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—CGA—conduct disorder	0.000172	0.00127	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.000172	0.00127	CbGpPWpGaD
Thioridazine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000171	0.00126	CbGpPWpGaD
Thioridazine—HTR1A—GPCR ligand binding—DRD4—conduct disorder	0.000171	0.00126	CbGpPWpGaD
Thioridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00017	0.00126	CbGpPWpGaD
Thioridazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00017	0.00126	CbGpPWpGaD
Thioridazine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00017	0.00126	CbGpPWpGaD
Thioridazine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.00017	0.00126	CbGpPWpGaD
Thioridazine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000167	0.00123	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—CGA—conduct disorder	0.000164	0.00121	CbGpPWpGaD
Thioridazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000163	0.0012	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—DRD4—conduct disorder	0.000163	0.0012	CbGpPWpGaD
Thioridazine—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000163	0.0012	CbGpPWpGaD
Thioridazine—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000161	0.00119	CbGpPWpGaD
Thioridazine—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.00016	0.00118	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—CGA—conduct disorder	0.000157	0.00116	CbGpPWpGaD
Thioridazine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.000156	0.00115	CbGpPWpGaD
Thioridazine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.000156	0.00115	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.000156	0.00115	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000155	0.00114	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—CGA—conduct disorder	0.000151	0.00112	CbGpPWpGaD
Thioridazine—HTR6—GPCR ligand binding—HTR2A—conduct disorder	0.000151	0.00111	CbGpPWpGaD
Thioridazine—HTR7—GPCR ligand binding—HTR2A—conduct disorder	0.00015	0.00111	CbGpPWpGaD
Thioridazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00015	0.00111	CbGpPWpGaD
Thioridazine—DRD2—GPCR ligand binding—DRD4—conduct disorder	0.00015	0.00111	CbGpPWpGaD
Thioridazine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00015	0.0011	CbGpPWpGaD
Thioridazine—HTR7—Circadian rythm related genes—EP300—conduct disorder	0.000149	0.0011	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—CGA—conduct disorder	0.000149	0.0011	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—CGA—conduct disorder	0.000149	0.0011	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.000149	0.0011	CbGpPWpGaD
Thioridazine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.000148	0.0011	CbGpPWpGaD
Thioridazine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.000148	0.00109	CbGpPWpGaD
Thioridazine—HTR2A—GPCR ligand binding—DRD4—conduct disorder	0.000148	0.00109	CbGpPWpGaD
Thioridazine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.000147	0.00109	CbGpPWpGaD
Thioridazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000147	0.00109	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.000147	0.00109	CbGpPWpGaD
Thioridazine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.000147	0.00109	CbGpPWpGaD
Thioridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000146	0.00108	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—CGA—conduct disorder	0.000146	0.00108	CbGpPWpGaD
Thioridazine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.000146	0.00108	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—CGA—conduct disorder	0.000146	0.00108	CbGpPWpGaD
Thioridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000146	0.00108	CbGpPWpGaD
Thioridazine—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000145	0.00107	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—DRD4—conduct disorder	0.000145	0.00107	CbGpPWpGaD
Thioridazine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000145	0.00107	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—DRD4—conduct disorder	0.000145	0.00107	CbGpPWpGaD
Thioridazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000139	0.00103	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000138	0.00102	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—CGA—conduct disorder	0.000137	0.00101	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—CGA—conduct disorder	0.000136	0.001	CbGpPWpGaD
Thioridazine—HTR1A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000135	0.001	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—CGA—conduct disorder	0.000135	0.000999	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.000135	0.000997	CbGpPWpGaD
Thioridazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000134	0.000992	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—DRD4—conduct disorder	0.000134	0.000992	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—CGA—conduct disorder	0.000133	0.000981	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—CGA—conduct disorder	0.000132	0.000978	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—DRD4—conduct disorder	0.00013	0.000963	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—DRD4—conduct disorder	0.00013	0.000962	CbGpPWpGaD
Thioridazine—DRD1—GPCR ligand binding—HTR2A—conduct disorder	0.00013	0.000957	CbGpPWpGaD
Thioridazine—DRD1—Circadian rythm related genes—EP300—conduct disorder	0.000129	0.000949	CbGpPWpGaD
Thioridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000129	0.000949	CbGpPWpGaD
Thioridazine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.000127	0.000935	CbGpPWpGaD
Thioridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000126	0.000932	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000126	0.000931	CbGpPWpGaD
Thioridazine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.000126	0.000929	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—CGA—conduct disorder	0.000125	0.000923	CbGpPWpGaD
Thioridazine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.000125	0.000922	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—CGA—conduct disorder	0.000125	0.000922	CbGpPWpGaD
Thioridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000124	0.000917	CbGpPWpGaD
Thioridazine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000124	0.000914	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—CGA—conduct disorder	0.000123	0.000909	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—DRD4—conduct disorder	0.000118	0.000875	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—DRD4—conduct disorder	0.000118	0.000874	CbGpPWpGaD
Thioridazine—HTR2A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000117	0.000864	CbGpPWpGaD
Thioridazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000115	0.00085	CbGpPWpGaD
Thioridazine—CHRM2—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000115	0.000848	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—DRD4—conduct disorder	0.000112	0.000829	CbGpPWpGaD
Thioridazine—HTR1A—GPCR ligand binding—HTR2A—conduct disorder	0.000111	0.000823	CbGpPWpGaD
Thioridazine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	0.000111	0.000819	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000108	0.000796	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—CGA—conduct disorder	0.000108	0.000794	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR ligand binding—HTR2A—conduct disorder	0.000106	0.000784	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—DRD4—conduct disorder	0.000102	0.000753	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—WASF1—conduct disorder	0.0001	0.000739	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—WASF1—conduct disorder	0.0001	0.000739	CbGpPWpGaD
Thioridazine—DRD2—GPCR ligand binding—HTR2A—conduct disorder	9.79e-05	0.000723	CbGpPWpGaD
Thioridazine—DRD2—Circadian rythm related genes—EP300—conduct disorder	9.71e-05	0.000717	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—DRD4—conduct disorder	9.66e-05	0.000713	CbGpPWpGaD
Thioridazine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	9.61e-05	0.00071	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	9.61e-05	0.000709	CbGpPWpGaD
Thioridazine—CHRM2—GPCR ligand binding—HTR2A—conduct disorder	9.46e-05	0.000698	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR ligand binding—HTR2A—conduct disorder	9.43e-05	0.000696	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—CGA—conduct disorder	9.25e-05	0.000683	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—CGA—conduct disorder	9.2e-05	0.000679	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—DRD4—conduct disorder	9.2e-05	0.000679	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—CGA—conduct disorder	8.81e-05	0.00065	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—DRD4—conduct disorder	8.77e-05	0.000647	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR ligand binding—HTR2A—conduct disorder	8.76e-05	0.000647	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	8.72e-05	0.000644	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—CGA—conduct disorder	8.69e-05	0.000642	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—WASF1—conduct disorder	8.62e-05	0.000636	CbGpPWpGaD
Thioridazine—HTR6—GPCR downstream signaling—HTR2A—conduct disorder	8.51e-05	0.000628	CbGpPWpGaD
Thioridazine—HTR7—GPCR downstream signaling—HTR2A—conduct disorder	8.5e-05	0.000628	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—DRD4—conduct disorder	8.48e-05	0.000626	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—DRD4—conduct disorder	8.35e-05	0.000617	CbGpPWpGaD
Thioridazine—HTR2A—GPCR downstream signaling—DRD4—conduct disorder	8.34e-05	0.000616	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	8.32e-05	0.000615	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—DRD4—conduct disorder	8.19e-05	0.000605	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—DRD4—conduct disorder	8.17e-05	0.000603	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—CGA—conduct disorder	8.12e-05	0.0006	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—CGA—conduct disorder	7.99e-05	0.00059	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—CGA—conduct disorder	7.98e-05	0.000589	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—CGA—conduct disorder	7.97e-05	0.000589	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—CGA—conduct disorder	7.85e-05	0.000579	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—CGA—conduct disorder	7.82e-05	0.000578	CbGpPWpGaD
Thioridazine—HTR6—Signaling by GPCR—HTR2A—conduct disorder	7.73e-05	0.000571	CbGpPWpGaD
Thioridazine—HTR7—Signaling by GPCR—HTR2A—conduct disorder	7.72e-05	0.00057	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—DRD4—conduct disorder	7.7e-05	0.000568	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—DRD4—conduct disorder	7.59e-05	0.00056	CbGpPWpGaD
Thioridazine—HTR2A—Signaling by GPCR—DRD4—conduct disorder	7.58e-05	0.000559	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—DRD4—conduct disorder	7.56e-05	0.000558	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—DRD4—conduct disorder	7.44e-05	0.000549	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—DRD4—conduct disorder	7.42e-05	0.000548	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—WASF1—conduct disorder	7.41e-05	0.000547	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—WASF1—conduct disorder	7.38e-05	0.000544	CbGpPWpGaD
Thioridazine—DRD1—GPCR downstream signaling—HTR2A—conduct disorder	7.33e-05	0.000541	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—CGA—conduct disorder	7.27e-05	0.000537	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—WASF1—conduct disorder	7.06e-05	0.000521	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—DRD4—conduct disorder	7e-05	0.000517	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—DRD4—conduct disorder	6.99e-05	0.000516	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—CGA—conduct disorder	6.9e-05	0.000509	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—DRD4—conduct disorder	6.89e-05	0.000509	CbGpPWpGaD
Thioridazine—DRD1—Signaling by GPCR—HTR2A—conduct disorder	6.65e-05	0.000491	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—WASF1—conduct disorder	6.51e-05	0.000481	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—WASF1—conduct disorder	6.4e-05	0.000473	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—WASF1—conduct disorder	6.39e-05	0.000472	CbGpPWpGaD
Thioridazine—HTR1A—GPCR downstream signaling—HTR2A—conduct disorder	6.3e-05	0.000465	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—WASF1—conduct disorder	6.29e-05	0.000464	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—WASF1—conduct disorder	6.27e-05	0.000463	CbGpPWpGaD
Thioridazine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	6.27e-05	0.000463	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—CGA—conduct disorder	6.16e-05	0.000455	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—DRD4—conduct disorder	6.02e-05	0.000445	CbGpPWpGaD
Thioridazine—ADRA1B—GPCR downstream signaling—HTR2A—conduct disorder	6e-05	0.000443	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—WASF1—conduct disorder	5.83e-05	0.00043	CbGpPWpGaD
Thioridazine—HTR1A—Signaling by GPCR—HTR2A—conduct disorder	5.72e-05	0.000422	CbGpPWpGaD
Thioridazine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	5.69e-05	0.00042	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—CGA—conduct disorder	5.67e-05	0.000418	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—CGA—conduct disorder	5.62e-05	0.000415	CbGpPWpGaD
Thioridazine—DRD2—GPCR downstream signaling—HTR2A—conduct disorder	5.53e-05	0.000408	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling by GPCR—HTR2A—conduct disorder	5.45e-05	0.000402	CbGpPWpGaD
Thioridazine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	5.43e-05	0.000401	CbGpPWpGaD
Thioridazine—CHRM2—GPCR downstream signaling—HTR2A—conduct disorder	5.34e-05	0.000395	CbGpPWpGaD
Thioridazine—ADRA1A—GPCR downstream signaling—HTR2A—conduct disorder	5.33e-05	0.000393	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—DRD4—conduct disorder	5.18e-05	0.000382	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—DRD4—conduct disorder	5.15e-05	0.00038	CbGpPWpGaD
Thioridazine—DRD2—Signaling by GPCR—HTR2A—conduct disorder	5.02e-05	0.000371	CbGpPWpGaD
Thioridazine—ADRA2A—GPCR downstream signaling—HTR2A—conduct disorder	4.95e-05	0.000366	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—DRD4—conduct disorder	4.93e-05	0.000364	CbGpPWpGaD
Thioridazine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	4.93e-05	0.000364	CbGpPWpGaD
Thioridazine—CHRM2—Signaling by GPCR—HTR2A—conduct disorder	4.85e-05	0.000358	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling by GPCR—HTR2A—conduct disorder	4.84e-05	0.000357	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—CGA—conduct disorder	4.8e-05	0.000354	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—HTR2A—conduct disorder	4.57e-05	0.000337	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—HTR2A—conduct disorder	4.56e-05	0.000337	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—DRD4—conduct disorder	4.55e-05	0.000336	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling by GPCR—HTR2A—conduct disorder	4.5e-05	0.000332	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—DRD4—conduct disorder	4.48e-05	0.00033	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—DRD4—conduct disorder	4.47e-05	0.00033	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—DRD4—conduct disorder	4.39e-05	0.000324	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—DRD4—conduct disorder	4.38e-05	0.000324	CbGpPWpGaD
Thioridazine—ADRA2A—Hemostasis—EP300—conduct disorder	4.15e-05	0.000306	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—DRD4—conduct disorder	4.07e-05	0.000301	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—HTR2A—conduct disorder	3.93e-05	0.00029	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—COMT—conduct disorder	3.92e-05	0.00029	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—MAOA—conduct disorder	3.9e-05	0.000288	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—COMT—conduct disorder	3.6e-05	0.000266	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—MAOA—conduct disorder	3.58e-05	0.000264	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—HTR2A—conduct disorder	3.38e-05	0.00025	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	3.36e-05	0.000248	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—HTR2A—conduct disorder	3.22e-05	0.000238	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—COMT—conduct disorder	3.12e-05	0.00023	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—MAOA—conduct disorder	3.09e-05	0.000228	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—conduct disorder	3e-05	0.000221	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—HTR2A—conduct disorder	2.97e-05	0.000219	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—HTR2A—conduct disorder	2.91e-05	0.000215	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—HTR2A—conduct disorder	2.87e-05	0.000212	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—HTR2A—conduct disorder	2.86e-05	0.000211	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—COMT—conduct disorder	2.78e-05	0.000205	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—MAOA—conduct disorder	2.76e-05	0.000204	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.68e-05	0.000198	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—HTR2A—conduct disorder	2.66e-05	0.000196	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—COMT—conduct disorder	2.56e-05	0.000189	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—MAOA—conduct disorder	2.54e-05	0.000187	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—COMT—conduct disorder	2.54e-05	0.000187	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—MAOA—conduct disorder	2.52e-05	0.000186	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.44e-05	0.00018	CbGpPWpGaD
Thioridazine—HTR6—Signaling Pathways—EP300—conduct disorder	2.42e-05	0.000179	CbGpPWpGaD
Thioridazine—HTR7—Signaling Pathways—EP300—conduct disorder	2.42e-05	0.000178	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—COMT—conduct disorder	2.17e-05	0.00016	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—MAOA—conduct disorder	2.15e-05	0.000159	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	2.09e-05	0.000154	CbGpPWpGaD
Thioridazine—DRD1—Signaling Pathways—EP300—conduct disorder	2.08e-05	0.000154	CbGpPWpGaD
Thioridazine—HTR1A—Signaling Pathways—EP300—conduct disorder	1.79e-05	0.000132	CbGpPWpGaD
Thioridazine—HTR2C—Signaling Pathways—EP300—conduct disorder	1.78e-05	0.000132	CbGpPWpGaD
Thioridazine—ADRA1B—Signaling Pathways—EP300—conduct disorder	1.71e-05	0.000126	CbGpPWpGaD
Thioridazine—ADRA2A—Metabolism—EP300—conduct disorder	1.68e-05	0.000124	CbGpPWpGaD
Thioridazine—DRD2—Signaling Pathways—EP300—conduct disorder	1.57e-05	0.000116	CbGpPWpGaD
Thioridazine—HTR2A—Signaling Pathways—EP300—conduct disorder	1.55e-05	0.000114	CbGpPWpGaD
Thioridazine—CYP2E1—Metabolism—EP300—conduct disorder	1.55e-05	0.000114	CbGpPWpGaD
Thioridazine—HRH1—Signaling Pathways—EP300—conduct disorder	1.54e-05	0.000114	CbGpPWpGaD
Thioridazine—CHRM2—Signaling Pathways—EP300—conduct disorder	1.52e-05	0.000112	CbGpPWpGaD
Thioridazine—ADRA1A—Signaling Pathways—EP300—conduct disorder	1.51e-05	0.000112	CbGpPWpGaD
Thioridazine—ADRA2A—Signaling Pathways—EP300—conduct disorder	1.41e-05	0.000104	CbGpPWpGaD
Thioridazine—CYP2C8—Metabolism—EP300—conduct disorder	1.34e-05	9.86e-05	CbGpPWpGaD
Thioridazine—CYP2C19—Metabolism—EP300—conduct disorder	1.19e-05	8.8e-05	CbGpPWpGaD
Thioridazine—CYP2D6—Metabolism—EP300—conduct disorder	1.1e-05	8.1e-05	CbGpPWpGaD
Thioridazine—CYP2C9—Metabolism—EP300—conduct disorder	1.09e-05	8.03e-05	CbGpPWpGaD
Thioridazine—CYP1A2—Metabolism—EP300—conduct disorder	9.29e-06	6.86e-05	CbGpPWpGaD
